People · Operator

RANDY S. THURMAN

Named in public records as an officer, director or promoter · active 2019–2020 · Pharmaceuticals

1
Companies
2
Filings
$49.4M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
TFF Pharmaceuticals, Inc.PharmaceuticalsSeries B$49.4M$9.2M2019
Operator network

RANDY S. THURMAN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

CATHERINE S. LEE · 2 companies · 1 sharedCATHERINE S. LEEAARON S. FLETCHER · 1 companies · 1 sharedAARON S. FLETCHERBRANDI S. ROBERTS · 1 companies · 1 sharedBRANDI S. ROBERTSBRIAN S. WINDSOR · 1 companies · 1 sharedBRIAN S. WINDSORGLENN S. MATTES · 1 companies · 1 sharedGLENN S. MATTESHARLAN S. WEISMAN · 1 companies · 1 sharedHARLAN S. WEISMANKIRK S. COLEMAN · 1 companies · 1 sharedKIRK S. COLEMANMALCOLM S. FAIRBAIRN · 1 companies · 1 sharedMALCOLM S. FAIRBA…MICHAEL S. PATANE · 1 companies · 1 sharedMICHAEL S. PATANEROBERT S. MILLS, JR. · 1 companies · 1 sharedROBERT S. MILLS, …STEPHEN S. ROCAMBOLI · 1 companies · 1 sharedSTEPHEN S. ROCAMB…THOMAS S. KING · 1 companies · 1 sharedTHOMAS S. KINGZAMANEH S. MIKHAK · 1 companies · 1 sharedZAMANEH S. MIKHAKTFF Pharmaceuticals, Inc. · $49.4M raisedTFF Pharmaceuticals, …RANDY S. THURMANRT
RANDY S. THURMAN Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside RANDY S. THURMAN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
CATHERINE S. LEE12
THOMAS S. KING11
ROBERT S. MILLS, JR.11
STEPHEN S. ROCAMBOLI11
HARLAN S. WEISMAN11
ZAMANEH S. MIKHAK11
KIRK S. COLEMAN11
MICHAEL S. PATANE11
MALCOLM S. FAIRBAIRN11
BRIAN S. WINDSOR11
AARON S. FLETCHER11
BRANDI S. ROBERTS11
GLENN S. MATTES11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.